ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
26 hedge funds and large institutions have $2.97M invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
4% more funds holding
Funds holding: 25 → 26 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
61% less capital invested
Capital invested by funds: $7.64M → $2.97M (-$4.67M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Platinum Management
New York
|
+$100K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$56.8K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$50.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$43.9K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$62K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$51K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$24K |
| 4 |
Jane Street
New York
|
-$17.1K |
| 5 |
Morgan Stanley
New York
|
-$11.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$441 | +245 | New |
|
ECTE Hedge Fund Activity: Q3 2014 in Review
26 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q3 2014, worth a combined $2.97M — down 61% from $7.64M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ECTE positions and 4 closed out — a net gain of 1 holder — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Platinum Management, adding an estimated $100K. The largest seller was Knoll Capital Management, exiting entirely with an estimated $62K sold.
- 26 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q3 2014, up from 25 in Q2 2014.
- Funds reported $2.97M of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q3 2014, down 61% quarter-over-quarter.
- 5 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q3 2014 and 4 closed out, a net change of +1 holder.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q3 2014 was Platinum Management, an estimated $100K added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q3 2014 was Knoll Capital Management, an estimated $62K sold.
Based on aggregated 13F filings for Q3 2014.